ArticleOncology reports2020

Inactivation of AKT/NF‑κB signaling by eurycomalactone decreases human NSCLC cell viability and improves the chemosensitivity to cisplatin.

Nahathai Dukaew et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.